Editorial: The role of epigenetic modification in radiotherapy and immuno-oncology in cancer: from bench to clinical application

• Hon-Yi Lin,
• Hon-Yi Lin,
• Hon-Yi Lin,
• Hon-Yi Lin,
• Michael W. Y. Chan,
• Vivian W. Y. Lui,
• Peter J. K. Kuppen,
• Shih-Kai Hung,
• Shih-Kai Hung,
• Shih-Kai Hung

Affiliations

Hon-Yi Lin

Department of Radiation Oncology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-yi, Taiwan

Hon-Yi Lin

Cancer Centre, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-yi, Taiwan

Hon-Yi Lin

School of Medicine, Tzu Chi University, Hualien, Taiwan

Hon-Yi Lin

Department of Biomedical Sciences, National Chung Cheng University, Chia-Yi, Taiwan

Michael W. Y. Chan

Department of Biomedical Sciences, National Chung Cheng University, Chia-Yi, Taiwan

Vivian W. Y. Lui

Georgia Cancer Center and Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, United States

Peter J. K. Kuppen

Department of Surgical Oncology, Leiden University Medical Centre, ZA, Leiden, Netherlands

Shih-Kai Hung

Department of Radiation Oncology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-yi, Taiwan

Shih-Kai Hung

Cancer Centre, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-yi, Taiwan

Shih-Kai Hung

School of Medicine, Tzu Chi University, Hualien, Taiwan